Back

Pharma

Highly Potent Active Pharmaceutical Ingredients

  • 16th June 2020
  • Zoom flag Zoom
  • ONLINE

HPAPI Live Event will provide you with the unique opportunity to build and manage your potent compound development strategy.

Our speakers will shed light on process innovation, technology, and safety perspectives for both highly potent active pharmaceutical ingredient (HPAPI) manufacturers and outsourcers.

Understanding strategic occupational health and safety elements within HPAPI projects. Request the brochure!

Read more

About

With five successfully executed editions of HPAPI events and a future one, scheduled for early 2021 in Italy, the Vonlanthen conferences and summits has an extensive experience under its belt and is bringing you an online edition of this event featuring the latest trends in the industry.

Don't miss out on the opening keynote speech from Dr. Ester Lovsin, the Head Product Stewardship, and Health at Takeda. He will cover his topic:  From Chemical to Containment.

Justin Mason-Home, Director at HPAPI Project Services Limited, will take a detailed look at the Strategic Occupational Health and Safety Elements within HPAPI Projects.

Containment Verification for Small Scale Plant for HPAPIs will be covered by Dr. Friederike Hermann, Head of Occupational Hygiene at Lonza.

Charlyn M. Reihman, Principal Occupational Health Consultant at SafeBridge Consultants, Inc. will present a high-interest subject: Uncertain Exposure – The Necessity for Robust Work Practices.

Who should attend

Executives, Directors, Heads, Leaders, Managers, Specialists, Toxicologists, Engineers and Fellows specializing in:

  • Industrial Hygiene
  • Laboratory Services
  • Occupational Toxicology
  • Manufacturing Science & Technology
  • Process Monitoring and Control
  • Tech Transfer
  • Risk Assessment
  • Validation
  • Health, Safety & Environment (HSE)
  • Research & Development
  • QA/QC

What industry

  • PharmaceuticalsBiotechnolog
  • Mechanical Engineering
  • Industrial Automation
  • Consulting

Key Practical Learning Points

  • Strategic occupational health an exposure monitoring
  • Current containment technologies
  • Safety first: defining exposure controls in the workplace
  • Respirator fit testing: an assessment of an adequate face seal for the worker
  • HPAPI project management systems

Dr. Ester Lovsin, CH

Head Product Stewardship and Health

Takeda

Ester Lovsin Barle, DVM, MSc, PhD, MScTox is the Head of Product Stewardship and Health at Takeda. Previously she has held corporate positions at Lonza and Novartis. Her responsibilities include regulatory and SDS related topics, scientific development and cross-organizational implementation of health based exposure limits (HBEL), compiling global policy product stewardship related process in sup­port of manufacturing in Takeda globally, as well as global implementation of industrial hygiene. She received her PhD in veterinary sciences from University of Ljubljana, Slovenia and a second masters degree in toxicology and risk assess­ment from Medical University in Vienna.Dr. Lovsin Barle is author/co-author of over 70 publications including peer-reviewed articles and book chapters. She is a member of several pharma industry and toxicological associations and boards and has served as the president of the Slovenian Society of toxicology. She lec­tures at several universities. Privately she is a mother of two and is enthusias­tic about balanced and healthy lifestyle which includes components of triathlon, mountain hiking and good food.

Justin Mason-Home, UK

Director

HPAPI Project Services Limited

Justin Mason-Home is an organic chemist with extensive health, safety, environmental and chemical engineering experience in senior technical, legal and commercial aspects of the pharmaceutical, biochemical, chemical and other industries. He has worked glob­ally and held senior positions in potent biopharmaceutical occupational health and safety global environmental consulting, board level positions in a biotechnology company and also been involved in corporate environmental management. Justin has worked on mul­tiple ADC projects and specialises in technically complex and strategic projects, including unique experiences in managing sensitive highly potent and toxic biopharmaceutical compound matters.

Silke Büchl, CH

Occupational Hygienist

Praevena AG

Silke Büchl is an experienced IOHA-certified occupational hygienist with about 20 years of experience in occupational hygiene. She received her IOHA certification after completing her postgraduate studies in work and health at ETH Zürich and the University of Lausanne in 2003. Before working as an occupational hygienist and deputy of the managing director at Praevena in 2014, she gained experience in the different fields of occupational hygiene, safety data sheets and hazard communication as well as participating in the internal board of OELs at Novartis.

Dr. Friederike Hermann, CH

Head of Occupational Hygiene

Lonza

Dr. Friederike Hermann is Head of Occupational Hygiene at Lonza Visp. She ob­tained her doctorate in the field of Analytical Chemistry with an emphasis on Element Speciation. In 2001, Dr. Hermann started as an Analytical Chemist in the Environmental Department and eventually transitioned into the field of Occupational Hygiene. She was significantly involved in the setup of high potent compound production at Lonza. She completed her Master of Advanced Stud­ies (MAS) degree on Work and Health at the ETH Zürich and the University of Lausanne. Dr. Hermann is a certified hygienist through the Swiss Society of Occupational Hygiene. She is a member of the steering committee of COP Con­tainment ISPE Affiliate DACH. She is also a member of the MAK Commission Switzerland and actively participates in a network of Occupational Hygienists, Physicians and Toxicologists, which form the Basel Chemical Industry (BCI). She is also a member of the Health Commission for the Lonza Visp site, which has over 3,000 employees. She lives in Wallis, Switzerland, where she enjoys run­ning, cycling and hiking.

Charlyn M. Reihman, US

Principal Occupational Health Consultant

SafeBridge Consultants, Inc.

Charlyn Reihman, MPH, CIH is a Principal Occupational Health Consultant for SafeBridge Consultants, Inc. She has over 30 years of safety and health experience in pharmaceutical/vaccine manufacturing and research & development, including 28 years at Merck. Her experience includes pharmaceutical industrial hygiene and exposure control, biosafety, program development, training, management system implementation, remediation, and conducting EHS compliance and pharmaceutical supply chain audits.  She also has experience providing safety, and industrial hygiene support to other industries include the lead industry, medical device manufacturing, construction, chemical manufacturing, and academic research and development. Charlyn has a wealth of experience, providing best practice recommendations for improving performance and minimizing risk.

Dr. Ester Lovsin, CH

Head Product Stewardship and Health

Takeda

Justin Mason-Home, UK

Director

HPAPI Project Services Limited

Silke Büchl, CH

Occupational Hygienist

Praevena AG

Dr. Friederike Hermann, CH

Head of Occupational Hygiene

Lonza

Charlyn M. Reihman, US

Principal Occupational Health Consultant

SafeBridge Consultants, Inc.

What our
participants
are saying

"Big thank you to all the speakers at the #5VLHPAPI Summit in Rome. Fantastic insights from a diverse group of industry experts and great presentations from all involved."

1
2
3
4
5

Jessica Pearson

Occupational Hygiene Consultant at Armstrong Environmental Limited

"We had very interesting discussions with the different participants about our industry and the latest trends. Thanks to Vonlanthen for organizing another great HPAPI."

1
2
3
4
5

Paolo Bento

Regional Sales Manager at ILC Dover

"Thanks for giving me the chance to talk about my view about Containment and GMP and how we have to work on it to fulfil future needs."

1
2
3
4
5

Richard Denk

Senior Consultant Aseptic Processing & Containment at SKAN AG